Literature DB >> 15868636

Relapsing polychondritis with aortitis without valvular involvement.

Young Hee Rho1, Seong Jae Choi, Youn Seon Choi, Young Ho Lee, Jong Dae Ji, Gwan Gyu Song.   

Abstract

Relapsing polychondritis is a multisystemic disease of unknown etiology that mainly involves the cartilaginous portions of the ear, nose, and trachea. Occasionally, there is involvement of the cardiovascular system, which usually results in severe morbidity and mortality. The most common manifestation of cardiovascular involvement is aortic root dilation resulting in aortic regurgitation. We describe the first case in Korea, a 51-year-old woman with relapsing polychondritis with aortitis, but without aortic valve involvement. She presented only with complaints of abdominal pain, and was successfully treated with corticosteroids and methotrexate.

Entities:  

Mesh:

Year:  2005        PMID: 15868636

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

Review 1.  Aortic involvement in relapsing polychondritis: case-based review.

Authors:  Mustafa Erdogan; Sinem Nihal Esatoglu; Gulen Hatemi; Vedat Hamuryudan
Journal:  Rheumatol Int       Date:  2019-11-25       Impact factor: 2.631

Review 2.  Clinical diagnosis and management of large vessel vasculitis: Takayasu arteritis.

Authors:  Soumya Chatterjee; Scott D Flamm; Carmela D Tan; E Rene Rodriguez
Journal:  Curr Cardiol Rep       Date:  2014-07       Impact factor: 2.931

3.  Successful treatment of aortic root dilatation in a patient with relapsing polychondritis.

Authors:  Aman Sharma; Tarun Mittal; Susheel Kumar; Arjun Datt Law; Ajay Wanchu; Rajiv Mahajan; Pradeep Bambery; Surjit Singh
Journal:  Clin Rheumatol       Date:  2010-04-13       Impact factor: 2.980

Review 4.  Efficacy of tocilizumab highlighted by FDG-PET/CT in a patient with relapsing polychondritis-associated aortitis.

Authors:  Ghassan Elourimi; Michael Soussan; Ursula Warzocha; Hélène Bugaud; Robin Dhôte; Sébastien Abad
Journal:  Rheumatol Int       Date:  2017-09-30       Impact factor: 2.631

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.